---
title: Treatment effects of empagliflozin in hospitalized heart failure patients across
  the range of left ventricular ejection fraction - Results from the EMPULSE trial
date: '2024-04-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38572654/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240404180633&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The clinical benefit of empagliflozin proved consistent
  across LVEF categories in the EMPULSE trial. These results support early in-hospital
  initiation of empagliflozin regardless of ...'
disable_comments: true
---
CONCLUSION: The clinical benefit of empagliflozin proved consistent across LVEF categories in the EMPULSE trial. These results support early in-hospital initiation of empagliflozin regardless of ...